Variant report
Variant | esv11587 |
---|---|
Chromosome Location | chr11:71274225-71275220 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:228)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:71274374-71274763 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr11:71274540-71274790 | GM12878 | blood: | n/a | n/a |
3 | BRCA1 | chr11:71274467-71274725 | HepG2 | liver: | n/a | n/a |
4 | CHD2 | chr11:71274596-71274796 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr11:71274640-71274790 | AG10803 | skin: | n/a | n/a |
6 | CTCF | chr11:71274700-71274850 | GM12869 | blood: | n/a | n/a |
7 | CTCF | chr11:71274680-71274830 | GM12871 | blood: | n/a | n/a |
8 | CTCF | chr11:71274580-71274730 | BJ | skin: | n/a | n/a |
9 | CTCF | chr11:71275020-71275170 | GM12875 | blood: | n/a | n/a |
10 | CTCF | chr11:71274680-71274830 | HEEpiC | esophagus: | n/a | n/a |
11 | CTCF | chr11:71274634-71274814 | Lung_OC | lung: | n/a | n/a |
12 | CTCF | chr11:71274660-71274810 | GM12875 | blood: | n/a | n/a |
13 | CTCF | chr11:71274606-71274854 | GM19240 | blood: | n/a | n/a |
14 | CTCF | chr11:71274660-71274810 | WI-38 | lung: | n/a | n/a |
15 | CTCF | chr11:71274720-71274870 | A549 | lung: | n/a | n/a |
16 | CTCF | chr11:71274640-71274790 | AoAF | blood vessel: | n/a | n/a |
17 | CTCF | chr11:71274640-71274790 | WERI-Rb-1 | eye: | n/a | n/a |
18 | CTCF | chr11:71274604-71274856 | GM13977 | blood: | n/a | n/a |
19 | CTCF | chr11:71274397-71274955 | HCT-116 | colon: | n/a | n/a |
20 | CTCF | chr11:71274660-71274810 | GM12873 | blood: | n/a | n/a |
21 | CTCF | chr11:71274472-71274958 | HepG2 | liver: | n/a | n/a |
22 | CTCF | chr11:71274660-71274810 | GM12872 | blood: | n/a | n/a |
23 | CTCF | chr11:71274500-71274877 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | CTCF | chr11:71274700-71274850 | HAc | cerebellar: | n/a | n/a |
25 | CTCF | chr11:71274422-71274998 | MCF-7 | breast: | n/a | n/a |
26 | CTCF | chr11:71274495-71274938 | GM12878 | blood: | n/a | n/a |
27 | CTCF | chr11:71274620-71274770 | GM12872 | blood: | n/a | n/a |
28 | CTCF | chr11:71274640-71274790 | SAEC | small airway: | n/a | n/a |
29 | CTCF | chr11:71275110-71275177 | GM20000 | blood: | n/a | n/a |
30 | CTCF | chr11:71274540-71274690 | A549 | lung: | n/a | n/a |
31 | CTCF | chr11:71274660-71274810 | HCT-116 | colon: | n/a | n/a |
32 | CTCF | chr11:71274660-71274810 | SK-N-SH_RA | brain: | n/a | n/a |
33 | CTCF | chr11:71274595-71274841 | Fibrobl | skin: | n/a | n/a |
34 | CTCF | chr11:71274540-71274690 | HCM | heart: | n/a | n/a |
35 | CTCF | chr11:71274580-71274730 | AG04450 | lung: | n/a | n/a |
36 | CTCF | chr11:71274597-71274847 | A549 | lung: | n/a | n/a |
37 | CTCF | chr11:71274612-71274830 | GM19239 | blood: | n/a | n/a |
38 | CTCF | chr11:71274680-71274830 | NHDF-neo | bronchial: | n/a | n/a |
39 | CTCF | chr11:71274620-71274770 | BJ | skin: | n/a | n/a |
40 | CTCF | chr11:71274660-71274810 | HPF | lung: | n/a | n/a |
41 | CTCF | chr11:71275040-71275310 | GM12870 | blood: | n/a | n/a |
42 | CTCF | chr11:71274597-71274861 | GM19238 | blood: | n/a | n/a |
43 | CTCF | chr11:71274660-71274810 | HL-60 | blood: | n/a | n/a |
44 | CTCF | chr11:71274617-71274850 | GM10248 | blood: | n/a | n/a |
45 | CTCF | chr11:71274640-71274790 | Caco-2 | colon: | n/a | n/a |
46 | CTCF | chr11:71274377-71275076 | SK-N-SH | brain: | n/a | n/a |
47 | CTCF | chr11:71274620-71274770 | AoAF | blood vessel: | n/a | n/a |
48 | CTCF | chr11:71274620-71274770 | HMF | breast: | n/a | n/a |
49 | CTCF | chr11:71274680-71274830 | GM12867 | blood: | n/a | n/a |
50 | CTCF | chr11:71274651-71274809 | Kidney_OC | kidney: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71156732..71161621-chr11:71272936..71276184,4 | MCF-7 | breast: | |
2 | chr11:71272055..71274887-chr11:71280546..71282110,2 | K562 | blood: | |
3 | chr11:71198148..71200436-chr11:71273726..71275977,2 | MCF-7 | breast: | |
4 | chr11:71176264..71179140-chr11:71273245..71275842,2 | MCF-7 | breast: | |
5 | chr11:71159116..71165503-chr11:71274687..71279227,9 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRTAP5-10 | TF binding region |
ENSG00000248903 | TF binding region |
ENSG00000172893 | chromatin interactions |
ENSG00000172890 | chromatin interactions |
ENSG00000254682 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75021914 | chr11:71274231-71274232 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs77106283 | chr11:71274236-71274237 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs189013573 | chr11:71274247-71274248 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs79071621 | chr11:71274260-71274261 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs77990334 | chr11:71274265-71274266 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs76701459 | chr11:71274282-71274283 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs75569384 | chr11:71274286-71274287 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs144432695 | chr11:71274293-71274294 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs563683178 | chr11:71274306-71274307 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs143101596 | chr11:71274345-71274346 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs533429141 | chr11:71274352-71274353 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs78824092 | chr11:71274353-71274354 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs78093986 | chr11:71274367-71274368 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs75863000 | chr11:71274368-71274369 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs77977057 | chr11:71274377-71274378 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs543040479 | chr11:71274390-71274391 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs561200245 | chr11:71274398-71274399 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs528604048 | chr11:71274432-71274433 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs546778877 | chr11:71274443-71274444 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs571473067 | chr11:71274444-71274445 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs200152323 | chr11:71274462-71274463 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs532397389 | chr11:71274503-71274504 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs550886523 | chr11:71274508-71274509 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs569210883 | chr11:71274520-71274521 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs535850453 | chr11:71274522-71274523 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs117235285 | chr11:71274527-71274528 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs78105622 | chr11:71274543-71274544 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs79830585 | chr11:71274578-71274579 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs74714711 | chr11:71274579-71274580 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs373655350 | chr11:71274582-71274583 | Bivalent Enhancer | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs74791057 | chr11:71274610-71274611 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs79499001 | chr11:71274627-71274628 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs566411115 | chr11:71274628-71274629 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs78931062 | chr11:71274633-71274634 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs75969118 | chr11:71274634-71274635 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs74838991 | chr11:71274655-71274656 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs76226497 | chr11:71274659-71274660 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs10792783 | chr11:71274671-71274672 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs76875127 | chr11:71274672-71274673 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs76312778 | chr11:71274684-71274685 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs80015845 | chr11:71274693-71274694 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs577811732 | chr11:71274697-71274698 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs545236316 | chr11:71274706-71274707 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs36100017 | chr11:71274728-71274729 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
45 | rs575919766 | chr11:71274729-71274730 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
46 | rs193149070 | chr11:71274753-71274754 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
47 | rs36045400 | chr11:71274758-71274759 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
48 | rs10792784 | chr11:71274790-71274791 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
49 | rs368669445 | chr11:71274791-71274792 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
50 | rs569691183 | chr11:71274810-71274811 | Enhancers Bivalent Enhancer Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71274200-71276400 | Bivalent Enhancer | HepG2 | liver |
2 | chr11:71274400-71274800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
3 | chr11:71274400-71274800 | Bivalent Enhancer | Osteobl | bone |
4 | chr11:71274400-71275000 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
5 | chr11:71274400-71275000 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr11:71274600-71274800 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
7 | chr11:71274600-71274800 | Enhancers | Brain Substantia Nigra | brain |
8 | chr11:71274600-71274800 | Bivalent/Poised TSS | Fetal Brain Male | brain |
9 | chr11:71274600-71275200 | Enhancers | Spleen | Spleen |
10 | chr11:71274800-71275000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr11:71274800-71275000 | Bivalent Enhancer | A549 | lung |
12 | chr11:71274800-71275400 | Enhancers | Liver | Liver |
13 | chr11:71274800-71277400 | Weak transcription | Brain Substantia Nigra | brain |
14 | chr11:71275000-71275200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr11:71275000-71275200 | Bivalent Enhancer | Duodenum Mucosa | Duodenum |
16 | chr11:71275000-71275200 | Bivalent Enhancer | Rectal Mucosa Donor 31 | rectum |
17 | chr11:71275000-71275400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr11:71275200-71275400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr11:71275200-71277200 | Weak transcription | Spleen | Spleen |
20 | chr11:71275200-71277400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |